Literature DB >> 8856181

Cardiac kallikrein in hypertensive and normotensive rats with and without diabetes.

J N Sharma1, U Kesavarao.   

Abstract

This study examined the effects of streptozotocin-induced diabetes on blood pressure and cardiac tissue kallikrein levels in WKYR and SHR. Streptozotocin-induced diabetes caused significant (p < 0.001) increase in SBP and DBP in WKYR and SHR as compared with their respective controls. We also observed that the active cardiac tissue kallikrein levels reduced greatly (p < 0.001) in diabetic WKYR and SHR than the normal rats. These findings suggest for the first time that the cardiac tissue kallikrein formation may have a greater role in the regulation of blood pressure and cardiac function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856181     DOI: 10.1016/0162-3109(96)00104-x

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  4 in total

Review 1.  The kinin system in hypertensive pathophysiology.

Authors:  Jagdish N Sharma
Journal:  Inflammopharmacology       Date:  2012-04-17       Impact factor: 4.473

2.  Differential responses to blood pressure and oxidative stress in streptozotocin-induced diabetic Wistar-Kyoto rats and spontaneously hypertensive rats: effects of antioxidant (honey) treatment.

Authors:  Omotayo O Erejuwa; Siti A Sulaiman; Mohd Suhaimi Ab Wahab; Kuttulebbai N S Sirajudeen; Md Salzihan Md Salleh; Sunil Gurtu
Journal:  Int J Mol Sci       Date:  2011-03-16       Impact factor: 5.923

3.  Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes.

Authors:  Meng Wu; Yeping Yang; Meng Wang; Fangfang Zeng; Qin Li; Wenjuan Liu; Shizhe Guo; Min He; Yi Wang; Jie Huang; Linuo Zhou; Yiming Li; Ji Hu; Wei Gong; Zhaoyun Zhang
Journal:  Front Pharmacol       Date:  2018-08-07       Impact factor: 5.810

4.  Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy.

Authors:  Dirk Westermann; Thomas Walther; Konstantinos Savvatis; Felcicitas Escher; Meike Sobirey; Alexander Riad; Michael Bader; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Diabetes       Date:  2009-03-10       Impact factor: 9.461

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.